| Financial Year |
March 31 2023 |
| Monetary Funds |
1,728,714,585.72 |
| Held-for-trading Financial Assets |
112,014,389.92 |
| Notes Receivable |
-- |
| Accounts Receivable |
2,628,667,727.01 |
| Advances to Suppliers |
86,391,260.74 |
| Other Receivables |
36,573,451.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,349,190,039.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
111,423,313.13 |
| Total Current Assets |
8,180,537,323.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
376,430,613.99 |
| Investment Properties |
6,555,626.97 |
| Fixed Assetes |
4,509,967,731.85 |
| Under-construction Projects |
2,950,511,592.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,087,733,518.80 |
| R&D expenses |
739,931,708.25 |
| Goodwill |
70,902,204.16 |
| Long-Term Deferred and Prepaid Expenses |
24,509,580.57 |
| Deferred Income Tax Assets |
194,785,393.12 |
| Other Non-Current Assets |
1,651,648.41 |
| Sub-Total of Non-Current Assets |
10,513,830,838.39 |
| Total Assets |
18,694,368,161.57 |
| Short-Term Loans |
1,685,990,763.89 |
| Trading Financial liabilities |
818,661.14 |
| Notes Payable |
403,202,648.80 |
| Accounts Payable |
795,084,831.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
147,300,624.82 |
| Taxes Payable |
205,054,426.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
704,986,427.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
951,960,014.80 |
| Other Current Liabilities |
4,742,534.66 |
| Sub-Total of Current Liabilities |
4,958,142,435.91 |
| Long-term Loans |
3,015,541,350.00 |
| Bonds Payable |
1,768,252,910.75 |
| Long-Term Accounts Payable |
53,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
171,985,335.45 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
163,518,534.00 |
| Sub-Total of Non-Current Liabilities |
5,806,373,903.44 |
| Total Liabilities |
10,764,516,339.35 |
| Paid-In Capital(Or Share Stock) |
1,483,475,087.00 |
| Capital Surplus |
1,338,566,565.32 |
| Surplus Reserve |
745,795,769.54 |
| LESS:Treasury Stock |
484,248,196.89 |
| Undistributed Profits |
4,418,662,693.57 |
| Minority Stockholder's Interest |
195,090,635.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,734,761,186.95 |
| Owner's Equity（Stockholder's Equity） |
7,929,851,822.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,694,368,161.57 |
